Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 100 publications
Elucidating the Cell Surfaceome to Accelerate Cancer Drug Development.
Journal: Cancer discovery
Published: April 04, 2024
The NIH-led research response to COVID-19.
Journal: Science (New York, N.Y.)
Published: February 02, 2023
Discovery of Novel Allosteric EGFR L858R Inhibitors for the Treatment of Non-Small-Cell Lung Cancer as a Single Agent or in Combination with Osimertinib.
Journal: Journal of medicinal chemistry
Published: September 30, 2022
Paradigms for the development of transformative medicines-lessons from the EGFR story.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: December 18, 2021
Catalyzing the field of precision oncology, one basket at a time.
Journal: Nature medicine
Published: April 11, 2018
From academia to industry: a road more travelled.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 29, 2017
Continued use of afatinib with the addition of cetuximab after progression on afatinib in patients with EGFR mutation-positive non-small-cell lung cancer and acquired resistance to gefitinib or erlotinib.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 01, 2017
Phase 1 study of twice weekly pulse dose and daily low-dose erlotinib as initial treatment for patients with EGFR-mutant lung cancers.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 12, 2017
Last Updated: 09/26/2026